A case of verrucous carcinoma treated by 5% imiquimod cream
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woong, J. | - |
dc.contributor.author | Choi, J.E. | - |
dc.contributor.author | Ahn, H.H. | - |
dc.contributor.author | Kye, Y.C. | - |
dc.contributor.author | Kim, S.N. | - |
dc.date.accessioned | 2021-09-09T15:58:36Z | - |
dc.date.available | 2021-09-09T15:58:36Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2008 | - |
dc.identifier.issn | 0494-4739 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/125362 | - |
dc.description.abstract | Verrucous carcinoma is a slow-growing, well-differentiated, low grade squamous cell carcinoma with little tendency to metastasize. The best treatment for verrucous carcinoma is excision, and Mohs microsurgery may also be a helpful technique. But some people can not undergo surgical excision because of poor general condition of the site and the size of the tumor. Herein, we report a case of verrucous carcinoma treated by 5% imiquimod cream. A 71-year-old male patient presented with a large hyperkeratotic verrucous plaque on the Rt. buttock. Diagnosis of verrucous carcinoma was based on typical clinical and histologic features. Surgical excision could not be performed due to me size of the tumor. Treatment with 5% imiquimod cream, a topical immune response modifier, applied every other day for 16 weeks, led to tumor regression. Four weeks after tibe end of treatment, the lesion was evaluated by punch biopsy. The histology just showed scar tissue change. This case demonstrates that the imiquimod cream might be an alternative treatment option for verrucous carcinoma. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.title | A case of verrucous carcinoma treated by 5% imiquimod cream | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ahn, H.H. | - |
dc.identifier.scopusid | 2-s2.0-51349085971 | - |
dc.identifier.bibliographicCitation | Korean Journal of Dermatology, v.46, no.6, pp.851 - 854 | - |
dc.relation.isPartOf | Korean Journal of Dermatology | - |
dc.citation.title | Korean Journal of Dermatology | - |
dc.citation.volume | 46 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 851 | - |
dc.citation.endPage | 854 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001261739 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Imiquimod | - |
dc.subject.keywordAuthor | Verrucous carcinoma | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.